677 related articles for article (PubMed ID: 30893293)
1. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
Guo Z; Zhang J; Fan L; Liu J; Yu H; Li X; Sun G
Med Sci Monit; 2019 Mar; 25():2079-2086. PubMed ID: 30893293
[TBL] [Abstract][Full Text] [Related]
2. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
3. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
Xie X; Xu X; Sun C; Yu Z
Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M
J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma.
Zhang PF; Wang F; Wu J; Wu Y; Huang W; Liu D; Huang XY; Zhang XM; Ke AW
J Cell Physiol; 2019 Mar; 234(3):2788-2794. PubMed ID: 30132868
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m
Chen YT; Xiang D; Zhao XY; Chu XY
Hum Cell; 2021 Nov; 34(6):1800-1811. PubMed ID: 34374933
[TBL] [Abstract][Full Text] [Related]
10. SNHG16 promotes hepatocellular carcinoma development via activating ECM receptor interaction pathway.
Zhang QJ; Li DZ; Lin BY; Geng L; Yang Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):41-49. PubMed ID: 34600815
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression.
Zhong JH; Xiang X; Wang YY; Liu X; Qi LN; Luo CP; Wei WE; You XM; Ma L; Xiang BD; Li LQ
J Cell Physiol; 2020 Feb; 235(2):1090-1102. PubMed ID: 31256427
[TBL] [Abstract][Full Text] [Related]
13. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
17. Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195.
Zhang H; Zhou D; Ying M; Chen M; Chen P; Chen Z; Zhang F
Med Sci Monit; 2016 Dec; 22():4820-4829. PubMed ID: 27932778
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma.
Li W; Xu W; Song JS; Wu T; Wang WX
Neoplasma; 2019 May; 66(3):397-404. PubMed ID: 30784284
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
